IQOS marketing strategies in the USA before and after US FDA modified risk tobacco product authorisation.

Regulatory efforts must be informed by ongoing surveillance of IQOS marketing efforts and its impacts, particularly how specific consumer subgroups (eg, tobacco non-users, women, young people) are impacted by marketing exposure.